Anti-Human CD9 Fab Fragment Antibody Blocks the Extracellular Vesicle-Mediated Increase in Malignancy of Colon Cancer Cells
Authors:
- Mark F. SantosMSMark F. Santos
- Germana RappaGRGermana Rappa
- Simona FontanaSimona Fontana
- Jana KarbanováJKJana Karbanová
- Feryal AalamFAFeryal Aalam
- Derek TaiDTDerek Tai
- Zhiyin LiZLZhiyin Li
- Marzia PucciMPMarzia Pucci
- Riccardo AlessandroRiccardo Alessandro
- Chikao MorimotoCMChikao Morimoto
- Denis CorbeilDenis Corbeil
- Aurelio LoricoAurelio Lorico
Open Access
Abstract
Intercellular communication between cancer cells themselves or with healthy cells in the tumor microenvironment and/or pre-metastatic sites plays an important role in cancer progression and metastasis. In addition to ligand–receptor signaling complexes, extracellular vesicles (EVs) are emerging as novel mediators of intercellular communication both in tissue homeostasis and in diseases such as cancer. EV-mediated transfer of molecular activities impacting morphological features and cell motility from highly metastatic SW620 cells to non-metastatic SW480 cells is a good in vitro example to illustrate the increased malignancy of colorectal cancer leading to its transformation and aggressive behavior. In an attempt to intercept the intercellular communication promoted by EVs, we recently developed a monovalent Fab fragment antibody directed against human CD9 tetraspanin and showed its effectiveness in blocking the internalization of melanoma cell-derived EVs and the nuclear transfer of their cargo proteins into recipient cells. Here, we employed the SW480/SW620 model to investigate the anti-cancer potential of the anti-CD9 Fab antibody. We first demonstrated that most EVs derived from SW620 cells contain CD9, making them potential targets. We then found that the anti-CD9 Fab antibody, but not the corresponding divalent antibody, prevented internalization of EVs from SW620 cells into SW480 cells, thereby inhibiting their phenotypic transformation, i.e., the change from a mesenchymal-like morphology to a rounded amoeboid-like shape with membrane blebbing, and thus preventing increased cell migration. Intercepting EV-mediated intercellular communication in the tumor niche with an anti-CD9 Fab antibody, combined with direct targeting of cancer cells, could lead to the development of new anti-cancer therapeutic strategies.Keywords
Funding Information
- National Institutes of Health (R15CA252990)
This publication has 92 references indexed in Scilit:
- CD9-Positive Microvesicles Mediate the Transfer of Molecules to Bovine Spermatozoa during Epididymal MaturationPLOS ONE, 2013
- Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic MicroRNAs Regulate Cancer Cell MetastasisJournal of Biological Chemistry, 2013
- MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory responseProceedings of the National Academy of Sciences, 2012
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through METNature Medicine, 2012
- Membrane vesicles as conveyors of immune responsesNature Reviews Immunology, 2009
- Endothelial adhesion receptors are recruited to adherent leukocytes by inclusion in preformed tetraspanin nanoplatformsJournal of Cell Biology, 2008
- The fusing ability of sperm is bestowed by CD9-containing vesicles released from eggs in miceProceedings of the National Academy of Sciences, 2008
- Cell motility through plasma membrane blebbingJournal of Cell Biology, 2008
- Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNature Cell Biology, 2007